Volume 13, Issue 3 (May 2011) 13, 359–360; 10.1038/aja.2011.34

Should prostate-specific antigen velocity be abandoned?

Stacy Loeb and H Ballentine Carter

Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA

Correspondence: Dr S Loeb, (stacyloeb@gmail.com); Dr HB Carter, (hcarter@jhmi.edu)